When California legalized adult-use cannabis, it did something bold and imperfect. It moved faster than science.
That was not recklessness. It was necessity. For decades, federal law treated cannabis as a Schedule I substance, effectively blocking large-scale, real-world research into its health, economic, environmental, and social effects. States that chose legalization were forced to build the plane while flying it.
Now, California is doing something rare in American drug policy. It is paying to understand the consequences of legalization, honestly and at scale.
Quietly, the California Department of Cannabis Control has awarded nearly $80 million since 2020 to fund academic research on cannabis. In late 2025 alone, the agency approved close to $30 million for 22 new projects across the University of California system and California State University campuses. The work spans public health, labor safety, environmental protection, taxation, consumer behavior, and criminal justice.
This is not prohibition by another name. It is legalization growing up.
Why the State Is Funding Cannabis Research at All
The DCC says it plainly on its website. Cannabis remains a Schedule I drug under federal law. That designation comes with strict limits on who can study it, how it can be studied, and what products can be used. As a result, the United States knows far less about cannabis than it does about alcohol, tobacco, or prescription drugs that cause far more documented harm.
California decided not to wait.
Some of the revenue collected from legal cannabis taxes is now being routed back into research to study the effects of adult-use legalization in the real world. Not lab rats. Not outdated government weed. Actual products, actual consumers, actual communities.
The goal is not to relitigate legalization. It is to make it work better.
What California Is Studying, Broadly
Look past the grant titles and a clear picture emerges.
Researchers …
Read More
Author: Javier Hasse / High Times
